367
Views
10
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Endothelial- and Platelet-Derived Microparticles Are Generated During Liver Resection in Humans

, , , , &
Pages 20-31 | Received 30 Jan 2015, Accepted 29 Apr 2015, Published online: 16 Sep 2015

REFERENCES

  • Wolf P. The nature and significance of platelet products in human plasma. Br J Haematol. 1967;13:269–288.
  • Meziani F, Tesse A, Andriantsitohaina R. Microparticles are vectors of paradoxical information in vascular cells including the endothelium: role in health and diseases. Pharmacol Rep. 2008;60:75–84.
  • Gutt CN, Oniu T, Wolkener F, et al. Prophylaxis and treatment of deep vein thrombosis in general surgery. Am J Surg. 2005;189:14–22.
  • Clagett GP, Anderson FA, Jr., Heit J, Levine MN, et al. Prevention of venous thromboembolism. Chest 1995;108:312S.334S.
  • Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood 1996;87:4651–4663.
  • Thiagarajan P, Tait JF. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem. 1991;266:24302–24307.
  • Mesri M, Altieri DC. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem. 1999;274:23111.23118.
  • Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost. 2007;97:425–434.
  • Falati S, Liu Q, Gross P, et al. Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin. J Exp Med. 2003;197:1585–1598.
  • Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, et al. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol. 2008;173:1210.
  • Boulanger CM, Scoazec A, Ebrahimian T, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001;104:2649–2652.
  • Amabile M, Cheng S, Renard JM, et al. Association of circulating endothelial microparticles with cardiometabolic risk factors in the Framingham Heart Study. Eur Heart J. 2014; 35:2972–9.
  • Delabranche X, Boisramé-Helms J, Asfar P, et al. Microparticles are new biomarkers of septic shock-induced disseminated intravascular coagulation. Intensive Care Med. 2013;39:1695–1703.
  • Schiro A, Wilkinson FL, Weston R, et al. Endothelial microparticles as conveyors of information in atherosclerotic disease. Atherosclerosis 2014;234:295–302.
  • Leonetti D, Reimund JM, Tesse A, et al. Circulating microparticles from Crohn's disease patients cause endothelial and vascular dysfunctions. PLoS One 2013;8: e73088.
  • Al Kaabi A, Traupe T, Stutz M, et al. Cause or effect of arteriogenesis: compositional alterations of microparticles from CAD patients undergoing external counterpulsation therapy. PLoS One 2012;7:e46822.
  • Park MS et al. Quantification of hypercoagulable state after blunt trauma: microparticle and thrombin generation are increased relative to injury severity, while standard markers are not. Surgery 2012;151:831–6.
  • Witek RP, Yang L, Liu R, et al. Liver cell-derived microparticles activate hedgehog signaling and alter gene expression in hepatic endothelial cells. Gastroenterology 2009;136:320–330.
  • Kornek M, Popov Y, Libermann TA, et al. Human T cell microparticles circulate in blood of hepatitis patients and induce fibrolytic activation of hepatic stellate cells. Hepatology 2011;53:230–242.
  • Ratou PE, Bresson J, Sainte-Marie, et al. Abnormal plasma microparticles impair vasoconstrictor response in patients with cirrhosis. Gastroenterology 2012;143:166–176.
  • Esch JS, Jurk K, Knoefel WT, et al. Platelet activation and increased tissue factor expression on monocytes in reperfusion injury following orthotopic liver transplantation. Platelets 2010;21:348–359.
  • Stravitz RT, Bowling R, Bradford RL, et al. Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure. Hepatology 2013;58:304–13.
  • Freeman CM, Quillin RC, Wilson GC, et al. Characterization of microparticles after hepatic ischemia-reperfusion injury. PLoS One 2014;30:e97945.
  • Brill A, Dashevsky O, Rivo J, et al. Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res. 2005;67:30–38.
  • Schmelzle M, Splith K, Andersen LW, et al. Increased plasma levels of microparticles expressing CD39 and CD133 in acute liver injury. Transplantation 2013;95:63–69.
  • Echrish HH, Xiao Y, Madden LA, et al. Effect of resection of localized pancreaticobiliary adenocarcinoma on angiogenic markers and tissue factor related pro-thrombotic and pro-angiogenic activity. Thromb Res. 2014;134:479–87.
  • Chang WJ, Toledo-Pereyra LH. Toll-like receptor signaling in liver ischemia and reperfusion. J Invest Surg. 2012;25:271–277.
  • Gasser O, Hess C, Miot S, et al. Characterisation and properties of ectosomes released by human polymorphonuclear neutrophils. Exp Cell Res. 2003;285:243–257.
  • Banz Y, Beldi G, Wu Y, et al. CD39 is incorporated into plasma microparticles where it maintains functional properties and impacts endothelial activation. Br J Haematol. 2008;142:627–637.
  • Sabatier F, Roux V, Anfosso F, et al. Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity. Blood 2002;99:3962–3970.
  • Stahl AL, Sartz L, Karpmann D. Complement activation in platelet-leukocyte complexes and microparticles in enterohemorrhagic Escherichia coli-induced haemolytic uremic syndrome. Blood 2011;117:5503–13.
  • Thaler J, Ay C, Mackman N, et al. Microparticle-associated tissue factor activity, venous thromboembolism an mortality on pancreatic, gastric, colorectal and brain cancer patients. J Thromb Haemost. 2012;10:1363–1370.
  • van Doormal F, Kleinjan A, Berckmans RJ, et al. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study. Thromb Haemost. 2012;108:160–165.
  • Welsch T, Muller SA, Ulrich A, et al. C-reactive protein as early predictor for infectious postoperative complications in rectal surgery. Int J Colorectal Dis. 2007;22:1499–1507.
  • Lacroix R, Robert S, Poncelet P, et al. ISTH SSC Workshop: Standardization of platelet-derived microparticle enumeration by flow cytometry with calibrated beads: results of the International Society on Thrombosis and Haemostasis. J Thromb Haemost. 2010;8:2571–2574.
  • Robert S, Poncelet P, Lacroix R, et al. Standarization of platelet-derived microparticle counting using calibreated beads and a Cytomics FC500 routine flow cytometer: A first step towards mutlicenter studies? J Thromb Haemost. 2009;7:190–197.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.